// App-Quantinova.ai

5046 : High-throughput chemical screening for sensitization of bladder cancer to gemcitabine and cisplatin chemotherapy

Researchers

Presenter

  • Yuki Kita

Principal Investigators

  • Takashi Kobayashi

  • Norihiko Masuda

  • Atsuro Sawada

  • Yoshiyuki Matsui

  • Takahiro Inoue

  • Tomomi Kamba

  • Osamu Ogawa

Medical Centers

  • Kyoto University, Kyoto, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Alcohol Dependence

  • Solid malignancies

Biomarkers

  • Proto-oncogene tyrosine-protein kinase ROS

Drug/Treatment

  • Gemcitabine

  • Disulfiram

  • Alconil

  • Cisplatin

  • Cysteine Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved